| Literature DB >> 36066940 |
Xiaowei Yan1, Hannah Husby1, Satish Mudiganti1, Madina Gbotoe1, Jake Delatorre-Reimer2, Kevin Knobel3, Andrew Hudnut4, J B Jones1.
Abstract
BACKGROUND: Electronic health record (EHR) systems are becoming increasingly complicated, leading to concerns about rising physician burnout, particularly for primary care physicians (PCPs). Managing the most common cardiometabolic chronic conditions by PCPs during a limited clinical time with a patient is challenging.Entities:
Keywords: EHR audit logs; cardiometabolic conditions; digital health; electronic health record; workflow efficiency
Year: 2022 PMID: 36066940 PMCID: PMC9490545 DOI: 10.2196/38385
Source DB: PubMed Journal: JMIR Med Inform
Figure 1Illustration of outpatient visit workflow and corresponding audit data. EHR: electronic health record; MA: medical assistant.
Figure 2Pre-post matched study design for CM-SHARE evaluation. CM-SHARE: Cardiometabolic Sutter Health Advanced Reengineered Encounter; EHR: electronic health record.
Summary statistics for the difference between time-motion–observed time and time derived from audit log data (N=101).
| Workflow event | Encounter, n (%) | Observed and audit data | |
|
|
| Values, mean (SD) | Values, median (IQR) |
| Check-in start | 101 (100) | 0.6 (1.5) | 0.3 (0.1 to 0.7) |
| Check-in end | 101 (100) | 1.0 (2.9) | 0.2 (−0.1 to 1.0) |
| Room start | —a | — | — |
| MAb logs in | 76 (75) | 0.2 (1.7) | 0.4 (−0.1 to 0.9) |
| MA logs off | 79 (78) | 0.1 (0.5) | 0.3 (−0.1 to 0.7) |
| Physician enters | — | — | — |
| Physician logs in | 76 (75) | −0.2 (1.5) | 0.2 (−0.6 to 1.0) |
| Physician logs off | 72 (71) | 0.3 (1.9) | −0.1 (−0.5 to 0.9) |
| Physician exits | 87 (86) | — | — |
| Observed time between physician log-off and physician exit time | 89 (88) | 0.8 (1.3) | 0.3 (0.1 to 0.7) |
aNot available in audit log data; represents a workflow “black hole,” as illustrated in Figure 1.
bMA: medical assistant.
Observed duration for each black hole using time-motion data and output from ANOVA.
| “Black hole” | Time interval (minute), mean (SD) | Variation explained by clinical staff (%) | Variation explained by patient characteristicsa (%) |
| MAb room to MA log-in | 0.73 (1.01) | 11.6 | 35.1 |
| MA log-off to exit | 0.51 (1.39) | 6.9 | 46.7 |
| Physician entering examination room to log in | 2.62 (1.61) | 62.2 | 14.8 |
| Physician log-off to exit | 0.82 (1.29) | 11.1 | 23 |
| Physician exit to patient exit | 2.72 (4.11) | 39.1 | 17.5 |
aPatient age, sex, race, and ethnicity.
bMA: medical assistant.
Summary of difference in time and 95% CI in comparing controls versus cases workflow measures during pilot period.
| Workflow measure and scheduled appointment time (minutes) | Difference between matched control in preperiod and matched cases (case and control; n=788) | Difference between matched control in postperiod and matched cases (case and control; n=669) | ||||||
|
| Values, n (%) | Mean (95% CI) | Values, n (%) | Mean (95% CI) | ||||
|
| ||||||||
|
| ≤20 | 325 (41.2) | −2.7 (−4.7 to −0.9) | .002 | 310 (46.3) | −1.6 (−3.2 to −0.1) | .02 | |
|
| ≥30 | 463 (58.8) | −0.6 (−3.1 to 2.2) | .11 | 359 (53.7) | −0.3 (−2.4 to 1.1) | .18 | |
|
| ||||||||
|
| ≤20 | 325 (41.2) | −0.6 (−1.9 to 2.0) | .35 | 310 (46.3) | 0.5 (−0.7 to 3.2) | .46 | |
|
| ≥30 | 463 (58.8) | −1.0 (−2.9 to 2.4) | .41 | 359 (53.7) | −0.7 (−2.1 to 2.0) | .29 | |
|
| ||||||||
|
| ≤20 | 325 (41.2) | −2.0 (−3.9 to −0.9) | .006 | 310 (46.3) | −1.9 (−3.8 to −0.5) | .009 | |
|
| ≥30 | 463 (58.8) | −1.3 (−3.4 to 0.5) | .12 | 359 (53.7) | −1.1 (−3.1 to 0.7) | .15 | |
|
| ||||||||
|
| ≤20 | N/Ab | N/A | N/A | N/A | 6 (−24 to 7) | .29 | |
|
| ≥30 | N/A | N/A | N/A | N/A | 12 (−27 to 10) | .33 | |
aEHR: electronic health record.
bN/A: not applicable.
Summary of difference in time and 95% CI in comparing controls versus cases workflow measures during the pilot period.
| Workflow measure and primary diagnosis | Difference between matched control in prestudy period and matched cases (case and control) (n=283) | Difference between matched control in poststudy period and matched cases (case and control) (n=312) | ||||||||||||
|
| Value, n (%) | Mean (95% CI) | Value, n (%) | Mean (95% CI) | ||||||||||
|
| ||||||||||||||
|
| Diabetes | 129 (45.6) | −2.8 (−3.9 to −0.2) | .03 | 145 (46.5) | −2.1 (−3.7 to −0.1) | .03 | |||||||
|
| Hypertension | 114 (40.3) | −3.5 (−5.2 to −0.1) | .04 | 124 (39.7) | −3.4 (−4.9 to −0.9) | .008 | |||||||
|
| Hyperlipidemia | 40 (14.1) | −3.7 (−6.2 to 1.8) | .19 | 43 (13.8) | −4.2 (−5.9 to 0.6) | .09 | |||||||
|
| ||||||||||||||
|
| Diabetes | 129 (45.6) | −2.1 (−3.9 to 0.8) | .12 | 145 (46.5) | −2.2 (−3.7 to 0.7) | .15 | |||||||
|
| Hypertension | 114 (40.3) | −0.5 (−1.2 to 1.3) | .36 | 124 (39.7) | −0.6 (−1.3 to 1.2) | .57 | |||||||
|
| Hyperlipidemia | 40 (14.1) | −0.1 (−1.0 to 1.7) | .61 | 43 (13.8) | 1.0 (−0.7 to 2.3) | .15 | |||||||
|
| ||||||||||||||
|
| Diabetes | 129 (45.6) | −4.3 (−5.2 to −2.4) | .007 | 145 (46.5) | −4.1 (−5.0 to −2.6) | .005 | |||||||
|
| Hypertension | 114 (40.3) | −2.9 (−3.8 to −0.5) | .02 | 124 (39.7) | −3.5 (−4.6 to −1.4) | .009 | |||||||
|
| Hyperlipidemia | 40 (14.1) | −2.2 (−3.7 to 1.0) | .14 | 43 (13.8) | −1.4 (−3.1 to 0.8) | .10 | |||||||
|
| ||||||||||||||
|
| Diabetes | N/Ab | N/A | N/A | 145 (46.5) | −19 (−34 to −2) | .04 | |||||||
|
| Hypertension | N/A | N/A | N/A | 124 (39.7) | −50 (−70 to −22) | .006 | |||||||
|
| Hyperlipidemia | N/A | N/A | N/A | 43 (13.8) | 4 (−11 to 15) | .35 | |||||||
aEHR: electronic health record.
bN/A: not applicable.
Summary of differences in time and 95% CI in comparing controls versus cases for the encounter-related workflow measures in the Cardiometabolic Sutter Health Advanced Reengineered Encounter spread period, stratified by scheduled appointment time.
| Workflow measure and scheduled appointment time (minutes) | Difference between matched control in postperiod and matched cases (case and control) | ||
|
| Values, mean (95% CI) | ||
|
| |||
|
| ≤20 | −5.3 (−7.5 to −0.7) | .002 |
|
| ≥30 | 3.7 (−6.1 to 3.9) | .37 |
|
| |||
|
| ≤2 | −2.0 (−4.2 to 1.7) | .15 |
|
| ≥30 | 3.4 (−4.9 to 2.1) | .23 |
|
| |||
|
| ≤20 | −4.0 (−5.7 to −1.8) | <.001 |
|
| ≥30 | −2.1 (−4.5 to −0.3) | .003 |
|
| |||
|
| ≤20 | −11 (−17 to −2) | .02 |
|
| ≥30 | −13 (−19 to −4) | .008 |
aEHR: electronic health record.
Summary of difference in time and 95% CI in comparing controls versus cases workflow measures during spread period, stratified by primary diagnosis.
| Workflow measure and primary diagnosis | Difference between matched control in postperiod and matched cases (case and control) | ||||||||
|
| Values, n (%) | Mean (95% CI) | |||||||
|
| Case (n=132) | Control (n=353) |
|
| |||||
|
| |||||||||
|
| Diabetes | 54 (40.9) | 157 (44.5) | −3.2 (−4.9 to −0.9) | .01 | ||||
|
| Hypertension | 41 (31.1) | 144 (40.8) | −2.9 (−4.0 to −0.1) | .04 | ||||
|
| Hyperlipidemia | 37 (28.0) | 52 (14.7) | −3.9 (−6.7 to 1.1) | .14 | ||||
|
| |||||||||
|
| Diabetes | 54 (40.9) | 157 (44.5) | −1.5 (−4.2 to 1.9) | .51 | ||||
|
| Hypertension | 41 (31.1) | 144 (40.8) | −1.9 (−5.2 to 3.7) | .49 | ||||
|
| Hyperlipidemia | 37 (28.0) | 52 (14.7) | −1.4 (−5.0 to 3.4) | .78 | ||||
|
| |||||||||
|
| Diabetes | 54 (40.9) | 157 (44.5) | −3.3 (−7.0 to 0.3) | .12 | ||||
|
| Hypertension | 41 (31.1) | 144 (40.8) | −2.1 (−4.7 to −0.2) | .03 | ||||
|
| Hyperlipidemia | 37 (28.0) | 52 (14.7) | −0.3 (−4.2 to 3.5) | .89 | ||||
|
| |||||||||
|
| Diabetes | 54 (40.9) | 157 (44.5) | −13 (−24 to −3) | .02 | ||||
|
| Hypertension | 41 (31.1) | 144 (40.8) | −24 (−38 to −12) | .009 | ||||
|
| Hyperlipidemia | 37 (28.0) | 52 (14.7) | −7 (−24 to 10) | .51 | ||||
aEHR: electronic health record.